对比增强超声VI-RADS评估膀胱癌肌层浸润的开发与验证
单中心前瞻性研究连续纳入疑似膀胱癌患者,按入组时间顺序以2:1分为训练集和验证集,训练集确定CEUS VI-RADS主要影像特征及肌层浸润可能性,验证集评估新手和专家阅片者的诊断效能和阅片者间一致性。CEUS VI-RADS在验证集中对肌层浸润评估表现出良好效能和阅片者间一致性。
要点
- 训练集确定肌层浸润的最佳CEUS VI-RADS截断值为4类及以上(Youden指数0.77)。
- 验证集中新手与专家阅片者AUC分别为0.80(95%CI:0.70,0.90)与0.88(95%CI:0.80,0.97),P=0.09。
- CEUS VI-RADS类别评估的阅片者间一致性:新手0.77(95%CI:0.65,0.85),专家0.87(95%CI:0.79,0.92),所有阅片者0.78(95%CI:0.70,0.84)。
核心结论
- 开发的CEUS VI-RADS在评估膀胱癌肌层浸润方面表现出良好的诊断效能和阅片者间一致性。
研究设计与样本
- 单中心前瞻性研究,连续纳入疑似膀胱癌患者,于2021年7月至2023年5月行经腹部或腔内CEUS,按入组时间顺序以2:1分为训练集(126例,中位年龄64岁[IQR 57-71],男107例)和验证集(67例,中位年龄64岁[IQR 56-69],男49例),以病理为参考标准。
诊断标准与关键数值
- 训练集确定肌层浸润的最佳CEUS VI-RADS截断值为4类及以上(Youden指数0.77)。
临床应用与阅片要点
- 验证集中CEUS VI-RADS对新手和专家阅片者均表现出良好效能,AUC分别为0.80(95%CI:0.70,0.90)和0.88(95%CI:0.80,0.97),两者差异无统计学显著(P=0.09)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Contrast-enhanced US (CEUS) can be used preoperatively for evaluating muscle invasion in bladder cancer, which is important for determining appropriate treatment. However, diagnostic criteria for assessing this at CEUS have not been standardized. Purpose To develop and validate a CEUS Vesical Imaging Reporting and Data System (VI-RADS) for evaluating muscle invasion in bladder cancer. Materials and Methods This single-center prospective study consecutively enrolled patients with suspected bladder cancer. Participants underwent transabdominal or intracavity CEUS between July 2021 and May 2023. Participants were divided into a training set and a validation set at a 2:1 ratio based on the chronologic order of enrollment. The training set was used to identify major imaging features to include in CEUS VI-RADS, and the likelihood of muscle invasion per category was determined using a pathologic reference standard. The optimal VI-RADS category cutoff for muscle invasion was determined with use of the maximum Youden index. The validation set was assessed by novice and expert readers and used to validate the diagnostic performance and interreader agreement of the developed system. Results Overall, 126 participants (median age, 64 years [IQR, 57-71 years]; 107 male) and 67 participants (median age, 64 years [IQR, 56-69 years]; 49 male) were included in the training and validation set, respectively. In the training set, the optimal CEUS VI-RADS category cutoff for muscle invasion was VI-RADS 4 or higher (Youden index, 0.77). In the validation set, CEUS VI-RADS achieved good performance for both novice and expert readers (area under the receiver operating characteristic curve, 0.80 [95% CI: 0.70, 0.90] vs 0.88 [95% CI: 0.80, 0.97]; P = .09). The interreader agreement regarding the evaluation of CEUS VI-RADS category was 0.77 (95% CI: 0.65, 0.85) for novice readers, 0.87 (95% CI: 0.79, 0.92) for expert readers, and 0.78 (95% CI: 0.70, 0.84) for all readers. Conclusion The developed CEUS VI-RADS showed good performance and interreader agreement for the assessment of muscle invasion in bladder cancer. Chinese Clinical Trial Registry no. ChiCTR2100049435 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Morrell in this issue.
引用
- Han J, Lin M, Lin Q, et al. Development and Validation of a Contrast-Enhanced US VI-RADS for Evaluating Muscle Invasion in Bladder Cancer. Radiology. 2024. PMID: 39254448. doi:10.1148/radiol.232815
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。